FRED ALGER MANAGEMENT, LLC – Ultragenyx Pharmaceutical Inc. Transaction History
FRED ALGER MANAGEMENT, LLC portfolio value:
$15.14M
portfolio value
FRED ALGER MANAGEMENT, LLC quarter portfolio value change:
-30.59%
quarter
Ultragenyx Pharmaceutical Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +39.48% | 103.51K shares | -498K | $41.41 | 365.71K |
Q2 2022 | share | Decrease | -6.28% | -17.57K shares | -4.67M | $59.66 | 262.20K |
Q1 2022 | share | Decrease | -4.68% | -13.72K shares | -4.36M | $72.62 | 279.77K |
Q4 2021 | share | Increase | +0.89% | 2.57K shares | -1.55M | $84.25 | 293.5K |
Q3 2021 | share | Increase | +51.97% | 99.49K shares | 7.98M | $90.19 | 290.92K |
Q2 2021 | share | Increase | +9.66% | 16.86K shares | -1.62M | $95.35 | 191.43K |
Q1 2021 | share | Decrease | -7.77% | -14.70K shares | -6.32M | $113.86 | 174.56K |
Q4 2020 | share | Decrease | -27.23% | -70.80K shares | 4.82M | $138.43 | 189.27K |
Q3 2020 | share | Increase | +26.06% | 53.76K shares | 5.23M | $82.19 | 260.08K |
Q2 2020 | share | Decrease | -23.55% | -63.56K shares | 4.14M | $78.22 | 206.32K |
Q1 2020 | share | Increase | +111.00% | 141.97K shares | 6.52M | $44.43 | 269.88K |
Q4 2019 | share | Increase | +6.36% | 7.64K shares | 318K | $42.71 | 127.90K |
Q3 2019 | share | Decrease | -1.91% | -2.34K shares | -2.64M | $42.78 | 120.26K |
Q2 2019 | share | Decrease | -31.12% | -55.40K shares | -4.56M | $63.5 | 122.60K |
Q1 2019 | share | Decrease | -10.78% | -21.50K shares | 3.67M | $69.36 | 178.00K |
Q4 2018 | share | Decrease | -9.61% | -21.20K shares | -8.17M | $43.48 | 199.51K |
Q3 2018 | share | Decrease | -5.64% | -13.19K shares | -1.13M | $76.34 | 220.72K |
Q2 2018 | share | Decrease | -31.05% | -105.33K shares | 683K | $76.87 | 233.91K |
Q1 2018 | share | Decrease | -12.84% | -49.99K shares | -755K | $50.99 | 339.24K |
Q4 2017 | share | Increase | +6.04% | 22.16K shares | -1.49M | $46.38 | 389.23K |
Q3 2017 | share | Increase | +8.89% | 29.95K shares | -1.38M | $53.26 | 367.06K |
Q2 2017 | share | Increase | +35.20% | 87.77K shares | 4.03M | $62.11 | 337.11K |
Q1 2017 | share | Increase | +168.50% | 156.47K shares | 10.37M | $67.78 | 249.33K |
Q4 2016 | share | Increase | +69.23% | 37.98K shares | 2.63M | $70.31 | 92.86K |
Q3 2016 | share | Decrease | -22.06% | -15.53K shares | 449K | $70.94 | 54.87K |
Q2 2016 | share | Decrease | -38.42% | -43.91K shares | -3.79M | $48.91 | 70.40K |
Q1 2016 | share | Increase | +3.93% | 4.32K shares | -5.10M | $63.31 | 114.32K |